Conjunctival flora in patients with type 1 or type 2 diabetes mellitus
Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromi...
Saved in:
Published in | Advances in therapy Vol. 24; no. 5; pp. 1028 - 1035 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.09.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 0741-238X 1865-8652 |
DOI | 10.1007/BF02877708 |
Cover
Abstract | Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Glycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Gram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 17 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%). Staphylococcus epidermidis (11.79%) and Staphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and S epidermidis (24.2%) and S aureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, S epidermidis (22%), S aureus (12%), and Corynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of S aureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%-80%); gram-negative organisms (15%-29%) and fungi (3%-13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in S aureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, S epidermidis and S aureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients. |
---|---|
AbstractList | Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Clycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Cram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 1 7 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%).Staphylococcus epidermidis (11.79%) andStaphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and Sepidermidis (24.2%) and Saureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, Sepidermidis (22%), Saureus (12%), andCorynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of Saureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%--80%); gram-negative organisms (15%--29%) and fungi (3%--13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in Saureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, Sepidermidis and Saureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients. Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Glycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Gram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 17 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%). Staphylococcus epidermidis (11.79%) and Staphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and S epidermidis (24.2%) and S aureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, S epidermidis (22%), S aureus (12%), and Corynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of S aureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%-80%); gram-negative organisms (15%-29%) and fungi (3%-13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in S aureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, S epidermidis and S aureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients. Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Glycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Gram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 17 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%). Staphylococcus epidermidis (11.79%) and Staphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and S epidermidis (24.2%) and S aureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, S epidermidis (22%), S aureus (12%), and Corynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of S aureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%-80%); gram-negative organisms (15%-29%) and fungi (3%-13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in S aureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, S epidermidis and S aureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients.Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms. Conjunctival flora develops soon after birth, and some saprophytic conjunctival flora play a pathogenic role when immune function is compromised, which can lead to serious infection. DM is one condition that may compromise immune status. In lacrimal function tests of DM patients, a decrease in breakup time (BUT) of lacrimal film and a decrease in Schirmer's test results were seen. In the present study, conjunctival flora in patients with DM was compared with that in controls with regard to type and duration of diabetes and results of lacrimal function tests. Seventeen patients with type 1 DM (n=34 eyes), 66 patients with type 2 DM (n=132 eyes), and 50 control subjects (n=100 eyes) were included. The control group consisted of age-matched patients with no ophthalmologic problems other than refractive error. Glycosylated hemoglobin values were measured with highpressure liquid chromatography with the Hi-AUTOA1c analyzer (Kyoto Daiichi Kagatu Co., Ltd., Kyoto, Japan). Type and duration of diabetes and demographic data were recorded, and routine ophthalmologic examinations were performed; the BUT of lacrimal film was determined, and the results of Schirmer's test were assessed. Microbiologic sampling was performed twice for both eyes with sterile cotton swabs. One sample was incubated in 2 mL of brain-heart infusion broth agar; the other was incubated for the presence of fungi in Sabouraud dextrose agar. Colony morphology, hemolysis, and Gram's stain, as well as catalase, oxidase, and coagulase tests were performed. No growth was observed in 12 of 17 patients (35.4%) with type 1 DM, 28 of 66 patients (21.2%) with type 2 DM, and 25 of 50 control subjects (50%). Staphylococcus epidermidis (11.79%) and Staphylococcus aureus (11.7%) were the most frequently isolated organisms in the type 1 DM group, and S epidermidis (24.2%) and S aureus (21.2%) were the predominant organisms in the type 2 DM group. In control subjects, S epidermidis (22%), S aureus (12%), and Corynebacterium spp (10%) were the most frequently isolated organisms, and the number of eyes with growth of S aureus was significantly higher in the type 2 DM group than in the other groups (P<.01). Patients with diabetes are more prone to postoperative endophthalmitis than are nondiabetics, and preoperative application of antiseptic or antimicrobial agents to the conjunctiva may not sterilize the area. Impaired integrity of the posterior capsule may also increase the risk of endophthalmitis. Postoperative endophthalmitis is usually associated with gram-positive organisms (75%-80%); gram-negative organisms (15%-29%) and fungi (3%-13%) account for a smaller number of cases. A high rate of resistance to penicillin, ampicillin, and tetracycline was observed in S aureus isolates, although resistance to vancomycin was absent, rendering this molecule the most effective therapeutic option. In this study, S epidermidis and S aureus were the 2 most frequently isolated organisms in patients with DM. It is concluded that the conjunctival flora in diabetic subjects differs from that in nondiabetic subjects. This should be considered preoperatively and postoperatively, and prophylactic and postoperative treatment should be administered accordingly to diabetic patients. |
Author | Bilen, Habib Baykal, Orhan Uslu, Hakan Astam, Neslihan Ates, Orhan Akcay, Gungor |
Author_xml | – sequence: 1 givenname: Habib surname: Bilen fullname: Bilen, Habib – sequence: 2 givenname: Orhan surname: Ates fullname: Ates, Orhan – sequence: 3 givenname: Neslihan surname: Astam fullname: Astam, Neslihan – sequence: 4 givenname: Hakan surname: Uslu fullname: Uslu, Hakan – sequence: 5 givenname: Gungor surname: Akcay fullname: Akcay, Gungor – sequence: 6 givenname: Orhan surname: Baykal fullname: Baykal, Orhan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18029329$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0EtLxDAQB_AgivvQix9AcvIgVCdpm8dRF1eFBS8K3kraTjFLXzapst_eyK4siOBhmDn8Zhj-M3LYdi0ScsbgigHI69slcCWlBHVApkyJNArFD8kUZMIiHqvXCZk5twbgIFN1TCZMAdcx11OyXHTtemwLbz9MTau6Gwy1Le2Nt9h6Rz-tf6N-0yNltBu2E6elNTl6dLTBurZ-dCfkqDK1w9Ndn5OX5d3z4iFaPd0_Lm5WUREz4SPJqkRCKWKViLJKhJE8QV2YElPDuDbh11RDjpAGXkkMVKNGLIzIOdMmnpOL7d1-6N5HdD5rrCvCE6bFbnSZUGksQKf_Qs44A6XiAM93cMwbLLN-sI0ZNtlPRAFcbkExdM4NWO0JZN_5Z_v8A4ZfuLA-ZNm1fjC2_mvlC_QvhSU |
CitedBy_id | crossref_primary_10_1016_j_exer_2021_108455 crossref_primary_10_1038_s41598_021_81507_x crossref_primary_10_3109_15569527_2012_692136 crossref_primary_10_1016_j_survophthal_2021_03_010 crossref_primary_10_1016_j_pcd_2017_05_009 crossref_primary_10_1016_j_visres_2017_03_002 crossref_primary_10_1016_j_biopha_2022_113530 crossref_primary_10_1038_eye_2013_103 crossref_primary_10_1097_ICU_0b013e32830d5da2 crossref_primary_10_3390_ijms22179641 crossref_primary_10_3389_fcimb_2019_00202 crossref_primary_10_1080_02713683_2017_1406528 crossref_primary_10_1186_s12866_024_03247_y crossref_primary_10_1097_ICO_0000000000000909 crossref_primary_10_22141_2309_8147_9_1_2021_229518 crossref_primary_10_1016_j_jtos_2023_04_003 crossref_primary_10_1038_eye_2009_218 crossref_primary_10_1080_02713680902725970 crossref_primary_10_4103_2347_5617_150212 crossref_primary_10_1136_bmjdrc_2019_001094 crossref_primary_10_1177_2058739218793550 crossref_primary_10_1016_j_bios_2012_04_030 crossref_primary_10_1016_j_jdiacomp_2018_09_015 crossref_primary_10_1016_j_fshw_2013_09_002 crossref_primary_10_15406_aovs_2024_14_00457 crossref_primary_10_3341_kjo_2019_0144 crossref_primary_10_4103_ijo_IJO_1485_21 crossref_primary_10_3109_08820538_2016_1170165 crossref_primary_10_1016_j_jtos_2017_10_006 crossref_primary_10_1136_bjophthalmol_2018_312709 crossref_primary_10_5402_2012_456209 |
Cites_doi | 10.1016/S0161-6420(13)31268-8 10.1016/S0891-5520(20)30648-6 10.1016/S0002-9394(14)76728-5 10.1001/archopht.1982.01030040253009 10.1111/j.1540-8191.2005.200472.x 10.1111/j.1755-3768.1975.tb01157.x 10.1016/S0008-4182(05)80004-3 10.1016/S0891-5520(20)30638-3 10.1016/0168-8227(93)90112-I 10.2337/diab.45.10.1289 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V 10.1136/bjo.80.8.681 10.1016/S0891-5520(20)30482-7 10.2337/diacare.10.4.483 10.2337/diabetes.38.8.1031 10.1016/S0002-9394(14)72773-4 10.1177/014860719802200277 10.1093/clinids/21.3.479 10.2337/diabetes.54.10.2904 10.2337/diacare.22.8.1354 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T7 8FD C1K FR3 M7N P64 7X8 |
DOI | 10.1007/BF02877708 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Technology Research Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1865-8652 |
EndPage | 1035 |
ExternalDocumentID | 18029329 10_1007_BF02877708 |
Genre | Journal Article |
GroupedDBID | --- -Y2 .86 .VR 06C 06D 0R~ 0VY 1N0 23M 2J2 2JY 2KG 2KM 2VQ 30V 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 8TC 95- 95. 95~ 96X AABHQ AACDK AAIAL AAIKX AAJKR AANXM AANZL AARHV AARTL AASML AATNV AAWCG AAWTL AAYIU AAYQN AAYTO AAYXX AAYZH ABAKF ABBRH ABDBE ABDZT ABFSG ABFTV ABHLI ABJNI ABJOX ABKCH ABMNI ABNWP ABPLI ABQBU ABTKH ABTMW ABXPI ACAOD ACCOQ ACDTI ACGFS ACHXU ACKNC ACMLO ACOKC ACPIV ACSNA ACSTC ACZOJ ADHHG ADHIR ADKPE ADRFC ADURQ AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFLOW AFOHR AFWTZ AFZKB AGAYW AGDGC AGJBK AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AIXLP AJBLW AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR ANMIH ARMRJ ATHPR AWSVR AXYYD AYFIA B-. BA0 BGNMA CAG CITATION COF CS3 CSCUP DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FERAY FFXSO FIGPU FLLZZ FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGRSB GJIRD GNWQR GQ7 H13 HF~ HG5 HG6 HMJXF HRMNR HZ~ IWAJR IXC IXD I~X I~Z J-C JBSCW JZLTJ KOV KPH LLZTM M4Y MA- MK0 NQJWS NU0 O9- O93 O9I OVD P2P P9S PF0 QOS R89 R9I ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNPRN SNX SOHCF SOJ SPKJE SRMVM SSLCW SV3 SZ9 SZN T13 TEORI TSG TSK TT1 TUC U2A U9L UG4 UTJUX UZXMN VC2 VDBLX VFIZW W48 WK8 Z45 ZMTXR ~A9 ~JE 2JN CGR CUY CVF ECM EIF NPM 7QL 7T7 8FD ABRTQ C1K FR3 M7N P64 7X8 |
ID | FETCH-LOGICAL-c316t-71f470d63846df46a724e9cade5a129a238590be05316f7e0d69e9eeca6b219a3 |
ISSN | 0741-238X |
IngestDate | Thu Sep 04 23:13:49 EDT 2025 Thu Sep 04 17:51:52 EDT 2025 Thu Apr 03 07:06:43 EDT 2025 Tue Jul 01 01:21:31 EDT 2025 Thu Apr 24 23:03:03 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c316t-71f470d63846df46a724e9cade5a129a238590be05316f7e0d69e9eeca6b219a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 18029329 |
PQID | 21210883 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_68536095 proquest_miscellaneous_21210883 pubmed_primary_18029329 crossref_primary_10_1007_BF02877708 crossref_citationtrail_10_1007_BF02877708 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-09-01 |
PublicationDateYYYYMMDD | 2007-09-01 |
PublicationDate_xml | – month: 09 year: 2007 text: 2007-09-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Advances in therapy |
PublicationTitleAlternate | Adv Ther |
PublicationYear | 2007 |
References | BM Desai (BF02877708_CR2) 1987; 35 J Rich (BF02877708_CR3) 2005; 54 M Delamaire (BF02877708_CR10) 1997; 14 U Seifart (BF02877708_CR4) 1994; 91 JB Dickey (BF02877708_CR22) 1991; 112 BF02877708_CR1 C Ramos-Remus (BF02877708_CR5) 1994; 12 JD Breen (BF02877708_CR17) 1995; 9 WB Philips (BF02877708_CR21) 1994; 101 CT Moeller (BF02877708_CR7) 2005; 40 LA Hruska (BF02877708_CR13) 2005; 20 AN Syed (BF02877708_CR15) 1992; 6 MR Tierney (BF02877708_CR20) 1995; 9 W Marhoffer (BF02877708_CR8) 1993; 19 JJ Pomposelli (BF02877708_CR12) 1998; 22 CP Nielson (BF02877708_CR9) 1989; 38 J Baum (BF02877708_CR25) 1995; 21 SD Januss (BF02877708_CR23) 1996; 80 BA Lipsky (BF02877708_CR18) 1987; 10 RO Schultz (BF02877708_CR19) 1983; 81 MS Osato (BF02877708_CR6) 1996 The Diabetes Control and Complications Trial Research Group (BF02877708_CR11) 1996; 45 S Stenson (BF02877708_CR16) 1982; 100 JA Fahmi (BF02877708_CR14) 1975; 53 L Apt (BF02877708_CR24) 1994; 119 |
References_xml | – volume: 101 start-page: 508 year: 1994 ident: BF02877708_CR21 publication-title: Ophthalmology doi: 10.1016/S0161-6420(13)31268-8 – volume: 9 start-page: 195 year: 1995 ident: BF02877708_CR20 publication-title: Infect Dis Clin North Am. doi: 10.1016/S0891-5520(20)30648-6 – volume: 112 start-page: 278 year: 1991 ident: BF02877708_CR22 publication-title: Am J Ophthalmol. doi: 10.1016/S0002-9394(14)76728-5 – volume: 100 start-page: 1275 year: 1982 ident: BF02877708_CR16 publication-title: Arch Ophthalmol. doi: 10.1001/archopht.1982.01030040253009 – volume: 20 start-page: 403 year: 2005 ident: BF02877708_CR13 publication-title: J Card Surg. doi: 10.1111/j.1540-8191.2005.200472.x – volume: 91 start-page: 235 year: 1994 ident: BF02877708_CR4 publication-title: Ophthalmologe – volume: 53 start-page: 237 year: 1975 ident: BF02877708_CR14 publication-title: Acta Ophthalmol. doi: 10.1111/j.1755-3768.1975.tb01157.x – volume: 40 start-page: 448 year: 2005 ident: BF02877708_CR7 publication-title: Can J Ophthalmol. doi: 10.1016/S0008-4182(05)80004-3 – volume: 9 start-page: 11 year: 1995 ident: BF02877708_CR17 publication-title: Infect Dis Clin North Am. doi: 10.1016/S0891-5520(20)30638-3 – volume: 19 start-page: 183 year: 1993 ident: BF02877708_CR8 publication-title: Diabetes Res Clin Pract. doi: 10.1016/0168-8227(93)90112-I – volume: 45 start-page: 1289 year: 1996 ident: BF02877708_CR11 publication-title: Diabetes doi: 10.2337/diab.45.10.1289 – volume: 14 start-page: 29 year: 1997 ident: BF02877708_CR10 publication-title: Diabet Med. doi: 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V – volume: 80 start-page: 681 year: 1996 ident: BF02877708_CR23 publication-title: Br J Ophthalmol. doi: 10.1136/bjo.80.8.681 – start-page: 191 volume-title: Ocular Infection and Immunity year: 1996 ident: BF02877708_CR6 – volume: 6 start-page: 789 year: 1992 ident: BF02877708_CR15 publication-title: Infect Dis Clin North Am. doi: 10.1016/S0891-5520(20)30482-7 – volume: 10 start-page: 483 year: 1987 ident: BF02877708_CR18 publication-title: Diabetes Care. doi: 10.2337/diacare.10.4.483 – volume: 38 start-page: 1031 year: 1989 ident: BF02877708_CR9 publication-title: Diabetes doi: 10.2337/diabetes.38.8.1031 – volume: 119 start-page: 701 year: 1994 ident: BF02877708_CR24 publication-title: Am J Ophthalmol. doi: 10.1016/S0002-9394(14)72773-4 – volume: 35 start-page: 130 year: 1987 ident: BF02877708_CR2 publication-title: Indian J Ophthalmol. – volume: 22 start-page: 77 year: 1998 ident: BF02877708_CR12 publication-title: J Patenter Enterai Nutr. doi: 10.1177/014860719802200277 – volume: 81 start-page: 107 year: 1983 ident: BF02877708_CR19 publication-title: Trans Am Ophthalmol Soc. – volume: 21 start-page: 475 year: 1995 ident: BF02877708_CR25 publication-title: Clin Infect Dis. doi: 10.1093/clinids/21.3.479 – volume: 54 start-page: 2904 year: 2005 ident: BF02877708_CR3 publication-title: Diabetes doi: 10.2337/diabetes.54.10.2904 – volume: 12 start-page: 375 year: 1994 ident: BF02877708_CR5 publication-title: Clin Exp Rheumatol. – ident: BF02877708_CR1 doi: 10.2337/diacare.22.8.1354 |
SSID | ssj0020758 |
Score | 1.9430015 |
Snippet | Patients with diabetes mellitus (DM) are prone to infection because glucose in the skin, urine, mucous membranes, and tears promotes growth of microorganisms.... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 1028 |
SubjectTerms | Conjunctiva - microbiology Diabetes Mellitus, Type 1 - microbiology Diabetes Mellitus, Type 2 - microbiology Glycated Hemoglobin A - analysis Humans Lacrimal Apparatus - microbiology |
Title | Conjunctival flora in patients with type 1 or type 2 diabetes mellitus |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18029329 https://www.proquest.com/docview/21210883 https://www.proquest.com/docview/68536095 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdb-7KX0X1nn4KNwmg9_CHL8mNSGsLo0j44kDcjOTLtljkldh66v353kWU5W8s-HmyMLGSj-3F3ku5-R8iHSKVxqiVG9y-Ux1RUeIrx0FOBUkLEHF7jfseXKZ_M2Od5PHdVOrfZJY36VPy4Na_kf6QKbSBXzJL9B8l2g0IDPIN84Q4ShvtfyfhkVX0Fu4QVypZHJay85ZGjSq17e6wBhp3_utv6Hbk4m3bhb4loTUhA3YY_9gkHRqA_tipqItWV6oDSGD1zvr50OBuCy2lwpsGN7b2Y1cuNGeJb22g3HJIuosrqJXBCPLD0c2NCjN4UPPbg2lGsJjm6BVDc05Lo1PQsbuAbxpLftLlvY9RDZC30hbNZ9px-ep6PZ2dneXY6z-6T_TBJ8Kx-fzgejabduhu8ImHYWM1_77LUtmPv-iV3LDa2Tkd2QB62qwU6NKJ_RO7p6jE5vDB04zfHNHPZc_UxPaQXjoj85gkZ9_FBt_igVxW1-KCID4qooAFdrc1TSC0-qMXHUzIbn2YnE6-tm-EVUcAbLwlKlvgL0KyML0rGZRIynWK6RSzBvZMwB3HqKywKEvAy0dA11anWheQKDJiMnpG9alXpF4QWRSo4L7VIkEaICalYiBVq4kXJQZuzAfloZy0vWlJ5rG2yzC0dtpvhAXnf9b02VCq39npnJz8HTYfHV7LSq02dh8h1J0R0dw8OvicSKA7IcyM19x3hg18bpi__OPor8sCB_jXZa9Yb_Qb8zka9bXH1E5nHgig |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Conjunctival+flora+in+patients+with+type+1+or+type+2+diabetes+mellitus&rft.jtitle=Advances+in+therapy&rft.au=Bilen%2C+Habib&rft.au=Ates%2C+Orhan&rft.au=Astam%2C+Neslihan&rft.au=Uslu%2C+Hakan&rft.date=2007-09-01&rft.issn=0741-238X&rft.eissn=1865-8652&rft.volume=24&rft.issue=5&rft.spage=1028&rft.epage=1035&rft_id=info:doi/10.1007%2FBF02877708&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0741-238X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0741-238X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0741-238X&client=summon |